Design, synthesis, and biological evaluation of novel bioactive thalidomide analogs as anticancer immunomodulatory agents

Documenti analoghi

• Design, synthesis, anticancer evaluation, and in silico ADMET analysis of novel thalidomide analogs as promising immunomodulatory agents
  di: Kotb, Anas Ramadan, et al.
  Pubblicazione: (2023)
• Design, Synthesis, and Biological Evaluation of New Potential Unusual Modified Anticancer Immunomodulators for Possible Non-Teratogenic Quinazoline-Based Thalidomide Analogs
  di: Mabrouk, Reda R., et al.
  Pubblicazione: (2023)
• Modified Benzoxazole-Based VEGFR-2 Inhibitors and Apoptosis Inducers: Design, Synthesis, and Anti-Proliferative Evaluation
  di: Elwan, Alaa, et al.
  Pubblicazione: (2022)
• Design and synthesis of thiazolidine-2,4-diones hybrids with 1,2-dihydroquinolones and 2-oxindoles as potential VEGFR-2 inhibitors: in-vitro anticancer evaluation and in-silico studies
  di: Taghour, Mohammed S., et al.
  Pubblicazione: (2022)
• The Quest for a Simple Bioactive Analog of Paclitaxel as a Potential Anticancer Agent
  di: Kingston, David G. I., et al.
  Pubblicazione: (2014)